neobookRx
Tools

Splenic Marginal Zone Lymphoma Study Group (SMZLSG) Prognostic Index

Estimates prognosis and predicts 5-year survival in adult patients with SMZL

Splenic Marginal Zone Lymphoma Study Group (SMZLSG) Prognostic Index

NeoHealth® ID 34710 · updated 12/14/2022